BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.90 Cr | ₹1.00 Cr | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.90 Cr |
| Mar2024 | ₹1.00 Cr |
| Mar2023 | ₹1.10 Cr |
| Mar2022 | ₹0.04 Cr |
| Mar2021 | ₹0.01 Cr |
How is Deferred Tax Assets / Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.90 Cr | -9.55 | |
| Mar2024 | ₹1.00 Cr | -9.63 | |
| Mar2023 | ₹1.10 Cr | 2,723.08 | |
| Mar2022 | ₹0.04 Cr | 457.14 | |
| Mar2021 | ₹0.01 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹116.6 Cr | 19.1% | 7.1% | -70.9% | Stock Analytics | |
| ADANI ENTERPRISES | ₹237,020.0 Cr | -2.8% | -15.3% | -17.8% | Stock Analytics | |
| REDINGTON | ₹15,733.2 Cr | -4.7% | -28.3% | -15% | Stock Analytics | |
| HONASA CONSUMER | ₹9,922.2 Cr | 3.7% | 0.6% | 30.5% | Stock Analytics | |
| MMTC | ₹8,290.5 Cr | -3% | -10.8% | 5.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,933.6 Cr | 2.2% | -11.2% | 17.2% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 19.1% |
7.1% |
-70.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses